StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific FDA High-Risk Device PMA & Supplement Approvals by Year

FDA High-Risk Device PMA & Supplement Approvals Granted to Thermo Fisher (openFDA)

Thermo Fisher Scientific FDA High-Risk Device PMA & Supplement Approvals: 12 in FY2025, up 140.0% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
12
Period ended Dec 31, 2025
Change on a year earlier
+140.0%
5 in FY2024
History
10 years
Since FY2016
Sources
1
openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries

Where the FY2025 figure comes from

Source: openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗

Reported in U.S. FDA openFDA Premarket Approval (PMA) API.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Thermo Fisher Scientific FDA High-Risk Device PMA & Supplement Approvals, annual FY2016–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-pma-company

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.